Atlas Trials

Combination Rucaparib With Nivolumab in Small Cell Lung Carcinoma

Clinical trial NCT03958045 · COMPLETED

Trial details

NCT number
NCT03958045
Sponsor
Zhonglin Hao
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Small Cell Lung Cancer
Start date
2019-09-04
Primary completion
2022-11-15
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.